B
bremelanotide
Product
by AMAG Pharmaceuticals
A melanocortin receptor agonist marketed as Vyleesi and approved in the United States for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women.
2 episodes featuring bremelanotide
unPAUSED with Dr. Mary Claire Haver
Testosterone enters the menopause conversation
The episode examines what women’s testosterone may do, where evidence remains thin, and how dosing and monitoring shape treatment risk.
Sep 1, 2026 · 1h 13m
unPAUSED with Dr. Mary Claire Haver
Menopause care still lags behind women’s lived experience
The conversation connects perimenopause symptoms to brain, cardiovascular, sexual, and bone health while examining why informed treatment remains difficult to access.
Aug 25, 2026 · 1h 14m